Patents by Inventor Peter F. Lenehan

Peter F. Lenehan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • System and method for using flow-mediated dilation to provide an adjusted vascular age as an indicator of risk of cardiovascular disease
    Patent number: 10568582
    Abstract: A diagnostic tool 104 and method 300 are used to modify vascular age scoring systems using flow-mediated dilation (FMD) data. The resulting FMD-adjusted vascular age calculator can be used to diagnose a person's potential for developing cardiovascular disease.
    Type: Grant
    Filed: March 13, 2014
    Date of Patent: February 25, 2020
    Assignee: Everist Genomics, Inc.
    Inventors: Peter F. Lenehan, Thomas Stephen Everist, III
  • System and method of assessing endothelial function
    Patent number: 10485429
    Abstract: A medical diagnostic system and method for assessing endothelial function comprise adjusting a reactive hyperemia indicator, measured in response to a stimulus, based on an anthropomorphic and/or demographic variable. The adjusted reactive hyperemia indicator provides a more accurate reflection of endothelial function and can be communicated to a clinician.
    Type: Grant
    Filed: July 1, 2016
    Date of Patent: November 26, 2019
    Assignee: Everist Genomics, Inc.
    Inventors: Peter F. Lenehan, Thomas Stephen Everist, III
  • SYSTEM AND METHOD OF ASSESSING ENDOTHELIAL FUNCTION
    Publication number: 20180199826
    Abstract: A medical diagnostic system and method for assessing endothelial function comprise adjusting a reactive hyperemia indicator, measured in response to a stimulus, based on an anthropomorphic and/or demographic variable. The adjusted reactive hyperemia indicator provides a more accurate reflection of endothelial function and can be communicated to a clinician.
    Type: Application
    Filed: July 1, 2016
    Publication date: July 19, 2018
    Inventors: Peter F. Lenehan, Thomas Stephen Everist, III
  • SYSTEM AND METHOD OF ASSESSING ENDOTHELIAL FUNCTION
    Publication number: 20170000355
    Abstract: A medical diagnostic system and method for assessing endothelial function comprise adjusting a reactive hyperemia indicator, measured in response to a stimulus, based on an anthropomorphic and/or demographic variable. The adjusted reactive hyperemia indicator provides a more accurate reflection of endothelial function and can be communicated to a clinician.
    Type: Application
    Filed: July 1, 2016
    Publication date: January 5, 2017
    Inventors: Peter F. Lenehan, Thomas Stephen Everist
  • SYSTEM AND METHOD FOR USING FLOW-MEDIATED DILATION TO PROVIDE AN ADJUSTED VASCULAR AGE AS AN INDICATOR OF RISK OF CARDIOVASCULAR DISEASE
    Publication number: 20160029972
    Abstract: A diagnostic tool 104 and method 300 are used to modify vascular age scoring systems using flow-mediated dilation (FMD) data. The resulting FMD-adjusted vascular age calculator can be used to diagnose a person's potential for developing cardiovascular disease.
    Type: Application
    Filed: March 13, 2014
    Publication date: February 4, 2016
    Inventors: Peter F. Lenehan, Thomas Stephen Everist, III
  • Prognostic signature for colorectal cancer recurrence
    Patent number: 9234245
    Abstract: An assay system is useful for predicting recurrence and/or non-recurrence of colorectal cancer in a patient. The assay system is adapted to analyze a patient sample for quantitative expression of a prognostic genetic profile correlated with colorectal cancer recurrence. The profile includes the expression of the nucleic acid sequences of SEQ ID NOS: 1, 2, 3, 4, and 5.
    Type: Grant
    Filed: January 17, 2012
    Date of Patent: January 12, 2016
    Assignee: Everist Genomics, Inc.
    Inventors: William P. Worzel, Peter F. Lenehan, Arpit Almal, David W. Fry
  • Prognostic Signature for Colorectal Cancer Recurrance
    Publication number: 20120185174
    Abstract: An assay system is useful for predicting recurrence and/or non-recurrence of colorectal cancer in a patient. The assay system is adapted to analyze a patient sample for quantitative expression of a prognostic genetic profile correlated with colorectal cancer recurrence. The profile includes the expression of the nucleic acid sequences of SEQ ID NOS: 1, 2, 3, 4, and 5.
    Type: Application
    Filed: January 17, 2012
    Publication date: July 19, 2012
    Applicant: Everist Genomics, Inc.
    Inventors: William P. Worzel, Peter F. Lenehan, Arpit Almal, David W. Fry